| Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey S Chatterjee, S Mehta, JT Sherer, RR Aparasu Drugs & aging 27, 987-997, 2010 | 79 | 2010 |
| Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US PP Rane, S Guha, S Chatterjee, RR Aparasu Research in Social and Administrative Pharmacy 13 (2), 358-363, 2017 | 76 | 2017 |
| Application of machine learning in predicting hospital readmissions: a scoping review of the literature Y Huang, A Talwar, S Chatterjee, RR Aparasu BMC medical research methodology 21, 1-14, 2021 | 74 | 2021 |
| Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia R Bhattacharya, S Chatterjee, RM Carnahan, RR Aparasu The American journal of geriatric pharmacotherapy 9 (6), 434-441, 2011 | 57 | 2011 |
| Anticholinergic medication use and risk of pneumonia in elderly adults: a nested case–control study S Chatterjee, RM Carnahan, H Chen, HM Holmes, ML Johnson, ... Journal of the American Geriatrics Society 64 (2), 394-400, 2016 | 52 | 2016 |
| Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score–adjusted, retrospective cohort study S Chatterjee, H Chen, ML Johnson, RR Aparasu The American journal of geriatric pharmacotherapy 10 (2), 83-94, 2012 | 48 | 2012 |
| Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted … S Chatterjee, H Chen, ML Johnson, RR Aparasu Drugs & aging 29, 807-817, 2012 | 38 | 2012 |
| Understanding patient preferences and unmet needs in non-alcoholic steatohepatitis (NASH): insights from a qualitative online bulletin board study NS Cook, SH Nagar, A Jain, MM Balp, M Mayländer, O Weiss, ... Advances in therapy 36, 478-491, 2019 | 37 | 2019 |
| Anticholinergic medication use and risk of fracture in elderly adults with depression S Chatterjee, V Bali, RM Carnahan, H Chen, ML Johnson, RR Aparasu Journal of the American Geriatrics Society 64 (7), 1492-1497, 2016 | 36 | 2016 |
| Anticholinergic medication use and risk of dementia among elderly nursing home residents with depression S Chatterjee, V Bali, RM Carnahan, ML Johnson, H Chen, RR Aparasu The American Journal of Geriatric Psychiatry 24 (6), 485-495, 2016 | 35 | 2016 |
| Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents RR Aparasu, S Chatterjee, S Mehta, H Chen Medical Care 50 (11), 961-969, 2012 | 35 | 2012 |
| Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics RR Aparasu, S Chatterjee, H Chen Annals of Pharmacotherapy 47 (4), 464-474, 2013 | 32 | 2013 |
| Risk of mortality associated with anticholinergic use in elderly nursing home residents with depression S Chatterjee, V Bali, RM Carnahan, H Chen, ML Johnson, RR Aparasu Drugs & aging 34, 691-700, 2017 | 28 | 2017 |
| Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression S Chatterjee, V Bali, RM Carnahan, H Chen, ML Johnson, RR Aparasu Research in Social and Administrative Pharmacy 16 (3), 329-335, 2020 | 25 | 2020 |
| Risk of dementia among elderly nursing home patients using paroxetine and other selective serotonin reuptake inhibitors V Bali, S Chatterjee, RM Carnahan, H Chen, ML Johnson, RR Aparasu Psychiatric Services 66 (12), 1333-1340, 2015 | 23 | 2015 |
| Anticholinergic medications and risk of dementia in older adults: Where are we now? S Chatterjee, A Talwar, RR Aparasu Expert Opinion on Drug Safety 19 (10), 1251-1267, 2020 | 21 | 2020 |
| Risk of mortality in elderly nursing home patients with depression using paroxetine V Bali, S Chatterjee, ML Johnson, H Chen, RM Carnahan, RR Aparasu Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (3 …, 2017 | 16 | 2017 |
| Antimuscarinic medication use in elderly patients with overactive bladder N Kachru, S Sura, S Chatterjee, RR Aparasu Drugs & aging 33, 755-763, 2016 | 16 | 2016 |
| Risk of hospitalization and use of first-versus second-generation antipsychotics among nursing home residents RR Aparasu, S Chatterjee, H Chen Psychiatric Services 65 (6), 781-788, 2014 | 14 | 2014 |
| Risk of cognitive decline associated with paroxetine use in elderly nursing home patients with depression V Bali, S Chatterjee, ML Johnson, H Chen, RM Carnahan, RR Aparasu American Journal of Alzheimer's Disease & Other Dementias® 31 (8), 678-686, 2016 | 12 | 2016 |
Rajender R. Aparasu, PhD, FAPhADepartment of Pharmaceutical Health Outcomes and Policy - University of Houston College of Pharmacy在 uh.edu 的电子邮件经过验证
